COMP <GO>
HUM vs JNJ // RETURN ON INVESTED CAPITAL (ROIC)
Humana Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: HUM 3
— JNJ 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: JNJ
LAST: $417.56 (+1.38%) • MKT CAP: $50.14B
roic
8.30%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
roic
25.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HUM VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HUM | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 8.30% | 25.50% | -17.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.4x | 18.5x | -0.10 | HUM | /valuation <GO> |
| Free Cash Flow Yield | 0.75% | 2.97% | -2.22 | JNJ | /fcf-yield <GO> |
| Operating Margin | 2.10% | 34.70% | -32.60 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 0.90% | 28.50% | -27.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 10.10% | 6.00% | +4.10 | HUM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.86% | 0.00% | +0.86 | HUM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.03 | 5.59 | -0.56 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 62.1 | -8.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.08 | -0.20 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.2x | 23.0x | +16.20 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.14B | $662.49B | -$612.35B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HUM REV | JNJ REV | HUM GROSS % | JNJ GROSS % | HUM FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.66B | $94.19B | — | 67.9% | $375.0M | $19.70B |
| FY 2024 | $117.76B | $88.82B | — | 69.1% | $2.39B | $19.84B |
| FY 2023 | $106.37B | $85.16B | — | — | -$805.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HUM // BETA 0.88
JNJ // BETA 1.08